Literature DB >> 30353055

Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.

Hyun-Suk Jung1, Yoosoo Chang1,2,3, Min-Jung Kwon2,4, Eunju Sung1,4, Kyung Eun Yun1, Yong Kyun Cho5, Hocheol Shin1,6, Seungho Ryu1,2,3.   

Abstract

OBJECTIVES: The role of smoking in the development of non-alcoholic fatty liver disease (NAFLD) remains controversial. We assessed the risk of incident NAFLD according to smoking status and urinary cotinine levels.
METHODS: We performed a cohort study of 199,468 Korean adults without NAFLD at baseline who were followed annually or biennially for a median of 4.1 years. The presence of fatty liver was determined using ultrasound. NAFLD severity was assessed using NAFLD fibrosis score (NFS), a non-invasive fibrosis marker.
RESULTS: During 1,070,991 person-years of follow-up, 45,409 participants developed NAFLD. Self-reported current smoking, pack-years, and urinary cotinine level were significantly associated with increased risk for NAFLD. For men, the multivariable-adjusted hazard ratios (aHR) (95% confidence intervals (CI)) for incident NAFLD comparing 10-19.9, and ≥20 pack-years to 0 pack-years were 1.25 (1.21- 1.29), and 1.36 (1.30-1.42), respectively; for women, aHR (95% CI) for NAFLD comparing 5-9.9, and ≥10 pack-years to 0 pack-years were 1.25 (1.04-1.50), and 1.46 (1.17-1.81), respectively. Smoking pack-years were also associated with increased risk for NAFLD plus intermediate or high fibrosis score. For men, the aHR (95% CI) for NAFLD plus intermediate or high NFS comparing ≥20 pack-years to 0 pack-years was 1.29 (1.18-1.42); for women, the aHR (95% CI) comparing ≥10 pack-years to 0 pack-years was 1.75 (1.12-2.73).
CONCLUSIONS: In a large cohort of young and middle-aged men and women, current smoking, pack-years, and urinary cotinine levels were positively associated with the risk of incident NAFLD, suggesting that smoking contributes to the development of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30353055     DOI: 10.1038/s41395-018-0283-5

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  21 in total

Review 1.  The Role of Life Style Modifications in Comprehensive Non-Alcoholic Fatty Liver Disease Treatment.

Authors:  Kathleen Viveiros
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

2.  Non-Alcoholic Fatty Liver Disease Is Strongly Associated with Smoking Status and Is Improved by Smoking Cessation in Japanese Males: A Retrospective Study.

Authors:  Haruka Takenaka; Tsuyoshi Fujita; Atsuhiro Masuda; Yoshihiko Yano; Akihiko Watanabe; Yuzo Kodama
Journal:  Kobe J Med Sci       Date:  2020-11-17

3.  Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018.

Authors:  Natalia I Heredia; Xiaotao Zhang; Maya Balakrishnan; Carrie R Daniel; Jessica P Hwang; Lorna H McNeill; Aaron P Thrift
Journal:  Prev Med       Date:  2021-12-01       Impact factor: 4.018

4.  PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample.

Authors:  Trang VoPham; Nicole J Kim; Kristin Berry; Jason A Mendoza; Joel D Kaufman; George N Ioannou
Journal:  Environ Res       Date:  2022-06-07       Impact factor: 8.431

5.  Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats.

Authors:  Pablo Alvarez Auth; Gustavo Ratti da Silva; Eduarda Carolina Amaral; Victor Fajardo Bortoli; Mariana Inocencio Manzano; Lauro Mera de Souza; Evellyn Claudia Wietzikoski Lovato; João Tadeu Ribeiro-Paes; Arquimedes Gasparotto Junior; Francislaine Aparecida Dos Reis Lívero
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

6.  Gut bacteria alleviate smoking-related NASH by degrading gut nicotine.

Authors:  Bo Chen; Lulu Sun; Guangyi Zeng; Zhe Shen; Kai Wang; Limin Yin; Feng Xu; Pengcheng Wang; Yong Ding; Qixing Nie; Qing Wu; Zhiwei Zhang; Jialin Xia; Jun Lin; Yuhong Luo; Jie Cai; Kristopher W Krausz; Ruimao Zheng; Yanxue Xue; Ming-Hua Zheng; Yang Li; Chaohui Yu; Frank J Gonzalez; Changtao Jiang
Journal:  Nature       Date:  2022-10-19       Impact factor: 69.504

7.  Associations Between Residential Exposure to Volatile Organic Compounds and Liver Injury Markers.

Authors:  Banrida Wahlang; Tyler C Gripshover; Hong Gao; Tatiana Krivokhizhina; Rachel J Keith; Israel D Sithu; Shesh N Rai; Aruni Bhatnagar; Craig J McClain; Sanjay Srivastava; Mathew C Cave
Journal:  Toxicol Sci       Date:  2021-12-28       Impact factor: 4.109

Review 8.  Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.

Authors:  Giandomenico Bisaccia; Fabrizio Ricci; Cesare Mantini; Claudio Tana; Gian Luca Romani; Cosima Schiavone; Sabina Gallina
Journal:  SAGE Open Med       Date:  2020-06-20

Review 9.  Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications.

Authors:  Claudio Tana; Stefano Ballestri; Fabrizio Ricci; Angelo Di Vincenzo; Andrea Ticinesi; Sabina Gallina; Maria Adele Giamberardino; Francesco Cipollone; Richard Sutton; Roberto Vettor; Artur Fedorowski; Tiziana Meschi
Journal:  Int J Environ Res Public Health       Date:  2019-08-26       Impact factor: 3.390

10.  Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver.

Authors:  Mika Aizawa; Seiichi Inagaki; Michiko Moriyama; Kenichiro Asano; Masayuki Kakehashi
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.